Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.
- Resource Type
- Article
- Source
- Cancer Imaging; 12/27/2022, Vol. 22 Issue 1, p1-13, 13p
- Subject
- Language
- ISSN
- 17405025